http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI1013991-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29800004a1adc1fb9b840e645d147be5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate | 2010-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2faada5c5b63e8f2fcb2a5ed293e40bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d82ebf1a14639ab3e1244be4a95c345 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12a5f7b6b852606957f85c2fe16adf01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e43fd1d2746828b951f38d4b1f1aae28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efceb9d67331f7394b1fa473ec4a9859 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e4d1ad378a838c686946d73591d704f |
| publicationDate | 2021-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-PI1013991-B1 |
| titleOfInvention | MONOCLONAL ANTIBODY, PHARMACEUTICAL COMPOSITION, SET OF REAGENTS USEFUL IN THE DIAGNOSIS OF ATHEROSCLEROTIC INJURIES, AND, USE OF AN ANTIBODY |
| abstract | MONOCLONAL ANTIBODY FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES, PHARMACEUTICAL COMPOSITION, SET OF REAGENTS USEFUL IN THE DIAGNOSIS OF ATHEROSCLEROTIC INJURIES, AND, USE OF AN ANTIBODY The present invention relates to the field of new technology and use, particularly human. The present invention provides new monoclonal antibodies that specifically and with high affinity recognize sulphatides and sulphated proteoglycans. Anti-sulfatide and anti-sulfate proteoglycan antibodies, described in this descriptive report, are important diagnostic and therapeutic agents to act on pathological processes associated with the appearance of atherosclerotic plaques. Accordingly, the invention provides pharmaceutical compositions comprising the monoclonal antibodies of the invention or fragments derived from these antibodies for therapeutic and diagnostic use in association with cardiovascular diseases. Additionally, the present invention relates to fragments of monoclonal antibodies which recognize sulphatides and sulphated proteoglycans, such that said fragments can be used in the treatment or diagnosis of this pathological condition. |
| priorityDate | 2009-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 102.